SignatureFD’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.3K Buy
2,678
+524
+24% +$14.1K ﹤0.01% 1600
2026
Q1
$39K Buy
2,154
+1,222
+131% +$23.3K ﹤0.01% 1875
2025
Q4
$20.3K Sell
932
-721
-44% -$20.7K ﹤0.01% 2113
2025
Q3
$53.9K Buy
1,653
+552
+50% +$20.4K ﹤0.01% 1598
2025
Q2
$39.1K Sell
1,101
-342
-24% -$11.1K ﹤0.01% 1718
2025
Q1
$49K Sell
1,443
-286
-17% -$10.3K ﹤0.01% 1581
2024
Q4
$56.3K Buy
1,729
+1,579
+1,053% +$65.4K ﹤0.01% 1520
2024
Q3
$7.31K Hold
150
﹤0.01% 2463
2024
Q2
$6.64K Hold
150
﹤0.01% 2414
2024
Q1
$8.41K Hold
150
﹤0.01% 2364
2023
Q4
$9.03K Hold
150
﹤0.01% 2302
2023
Q3
$10.1K Hold
150
﹤0.01% 2212
2023
Q2
$10.4K Hold
150
﹤0.01% 2222
2023
Q1
$7.23K Hold
150
﹤0.01% 2356
2022
Q4
$7.49K Hold
150
﹤0.01% 2273
2022
Q3
$6K Hold
150
﹤0.01% 2360
2022
Q2
$8K Hold
150
﹤0.01% 2230
2022
Q1
$5K Hold
150
﹤0.01% 2481
2021
Q4
$7K Hold
150
﹤0.01% 2271
2021
Q3
$8K Hold
150
﹤0.01% 2182
2021
Q2
$6K Hold
150
﹤0.01% 2214
2021
Q1
$4K Hold
150
﹤0.01% 2254
2020
Q4
$4K Hold
150
﹤0.01% 2033
2020
Q3
$5K Hold
150
﹤0.01% 1902
2020
Q2
$6K Buy
+150
New +$5.86K ﹤0.01% 1740

Other funds holding LEGN

SignatureFD's LEGN Position: Q2 2026 in Review

SignatureFD increased its Legend Biotech (LEGN) stake by 24% in Q2 2026, buying an estimated $14.1K and bringing the position to 2,678 shares worth $77.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1600.

SignatureFD first reported a position in LEGN in Q2 2020 and has held it in 25 quarters since. 31 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • SignatureFD held 2,678 shares of Legend Biotech worth $77.3K as of Q2 2026.
  • SignatureFD bought 524 Legend Biotech shares in Q2 2026, an estimated $14.1K.
  • Legend Biotech made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1600 holding.
  • SignatureFD first reported a position in Legend Biotech in Q2 2020 and has held it in 25 quarters since.
  • 31 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.